509 related articles for article (PubMed ID: 26824730)
41. The Ameliorative Effects of a Tocotrienol-Rich Fraction on the AGE-RAGE Axis and Hypertension in High-Fat-Diet-Fed Rats with Metabolic Syndrome.
Cheng HS; Ton SH; Tan JBL; Abdul Kadir K
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28880217
[TBL] [Abstract][Full Text] [Related]
42. Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-γ).
Chen M; Li H; Wang G; Shen X; Zhao S; Su W
Metabolism; 2016 Apr; 65(4):441-53. PubMed ID: 26975536
[TBL] [Abstract][Full Text] [Related]
43. Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5.
Lee JJ; Wang PW; Yang IH; Wu CL; Chuang JH
Int J Biochem Cell Biol; 2015 Jul; 64():1-10. PubMed ID: 25783987
[TBL] [Abstract][Full Text] [Related]
44. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice.
Grossin N; Auger F; Niquet-Leridon C; Durieux N; Montaigne D; Schmidt AM; Susen S; Jacolot P; Beuscart JB; Tessier FJ; Boulanger E
Mol Nutr Food Res; 2015 May; 59(5):927-38. PubMed ID: 25655894
[TBL] [Abstract][Full Text] [Related]
45. Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects.
Hagen I; Schulte DM; Müller N; Martinsen J; Türk K; Hedderich J; Schreiber S; Laudes M
Cytokine; 2015 Jun; 73(2):265-9. PubMed ID: 25802195
[TBL] [Abstract][Full Text] [Related]
46. Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.
Lopez-Moreno J; Quintana-Navarro GM; Camargo A; Jimenez-Lucena R; Delgado-Lista J; Marin C; Tinahones FJ; Striker GE; Roche HM; Perez-Martinez P; Lopez-Miranda J; Yubero-Serrano EM
Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28233454
[TBL] [Abstract][Full Text] [Related]
47. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
[TBL] [Abstract][Full Text] [Related]
48. Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study.
Kim Y; Keogh JB; Deo P; Clifton PM
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545555
[TBL] [Abstract][Full Text] [Related]
49. Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
Pereira ENGDS; Silvares RR; Flores EEI; Rodrigues KL; Ramos IP; da Silva IJ; Machado MP; Miranda RA; Pazos-Moura CC; Gonçalves-de-Albuquerque CF; Faria-Neto HCC; Tibiriça E; Daliry A
PLoS One; 2017; 12(6):e0179654. PubMed ID: 28628674
[TBL] [Abstract][Full Text] [Related]
50. Differential Receptor for Advanced Glycation End Products Expression in Preeclamptic, Intrauterine Growth Restricted, and Gestational Diabetic Placentas.
Alexander KL; Mejia CA; Jordan C; Nelson MB; Howell BM; Jones CM; Reynolds PR; Arroyo JA
Am J Reprod Immunol; 2016 Feb; 75(2):172-80. PubMed ID: 26682535
[TBL] [Abstract][Full Text] [Related]
51. Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells.
Rashid G; Benchetrit S; Fishman D; Bernheim J
Kidney Int; 2004 Sep; 66(3):1099-106. PubMed ID: 15327404
[TBL] [Abstract][Full Text] [Related]
52. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
[TBL] [Abstract][Full Text] [Related]
53. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Choi YG; Lim S
J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
[TBL] [Abstract][Full Text] [Related]
54. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
[TBL] [Abstract][Full Text] [Related]
55. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
56. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G
Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693
[TBL] [Abstract][Full Text] [Related]
57. Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.
Thallas-Bonke V; Coughlan MT; Tan AL; Harcourt BE; Morgan PE; Davies MJ; Bach LA; Cooper ME; Forbes JM
Nephrology (Carlton); 2013 Jan; 18(1):47-56. PubMed ID: 23046363
[TBL] [Abstract][Full Text] [Related]
58. Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.
Linkens AMA; Houben AJHM; Kroon AA; Schram MT; Berendschot TTJM; Webers CAB; van Greevenbroek M; Henry RMA; de Galan B; Stehouwer CDA; Eussen SJMP; Schalkwijk CG
Am J Clin Nutr; 2022 Feb; 115(2):444-455. PubMed ID: 34581759
[TBL] [Abstract][Full Text] [Related]
59. Potential involvement of dietary advanced glycation end products in impairment of skeletal muscle growth and muscle contractile function in mice.
Egawa T; Tsuda S; Goto A; Ohno Y; Yokoyama S; Goto K; Hayashi T
Br J Nutr; 2017 Jan; 117(1):21-29. PubMed ID: 28093090
[TBL] [Abstract][Full Text] [Related]
60. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
